High-Concentration Nitrous Oxide for Dental Procedural Sedation in Children

Sponsor
Bnai Zion Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT02886351
Collaborator
(none)
30
1
17

Study Details

Study Description

Brief Summary

The use of nitrous oxide as a sedative agent is very common in pediatric dentistry. In concentrations up to 50% it is considered as mild sedation and it is very safe. Despite its safety and widespread of its use nitrous oxide is not a potent drug and many times dentists fail to gain cooperation in moderate or high anxious children, and the alternatives are to use moderate sedation with drugs such as Midazolam, Atarax or general anesthesia. Higher concentration was not conducted in Pediatry densitery. The aim of this study is to compare the effectivity and safety of providing nitrous oxide at increasing concentrations 60%, 70% with 50% parameters, sedation depth, adverse events and cooperation of the child during the dental treatment.Our hypothesis is that nitrous oxide in concentrations higher than 50% up to 70% is a safe and effective sedation method in dental treatment of children.

Condition or Disease Intervention/Treatment Phase
  • Drug: Nitrous Oxide
N/A

Detailed Description

Nitrous oxide/oxygen in varying concentrations has been successfully used for many years to provide sedation and analgesia for a variety of painful procedures in children. The use of nitrous oxide as a sedative agent is very common in pediatric dentistry. In concentrations up to 50% it is considered as mild sedation and it is very safe. It is usually used for mild or moderate anxiety state because it is not so potent in concentrations up to 50 %. Despite its safety and widespread of its use nitrous oxide is not a potent drug and many times dentists fail to gain cooperation in moderate or high anxious children, and the alternatives are to use moderate sedation with drugs such as Midazolam, Atarax or general anesthesia. Nitrous oxide 50% is the most common concentration in use but the results of the sedation does not always provide a satisfactory cooperation, higher concentration was not conducted in Pediatry densitery. The aim of this study is to compare the effectivity and safety of providing nitrous oxide at increasing concentrations 60%, 70% with 50% parameters, sedation depth, adverse events and cooperation of the child during the dental treatment.Our hypothesis is that nitrous oxide in concentrations higher than 50% up to 70% is a safe and effective sedation method in dental treatment of children.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
High-Concentration Nitrous Oxide for Dental Procedural Sedation in Children
Study Start Date :
Jan 1, 2017
Anticipated Primary Completion Date :
Jan 1, 2018
Anticipated Study Completion Date :
Jun 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: nitrous oxide

Administration of high concentration of nitrous oxygen in pediatric dentistry

Drug: Nitrous Oxide
Nitrous Oxide at 60%-70% concentration administrated by mask, to achieve cooperation in Pediatric dentisry
Other Names:
  • Dinitrogen monoxide
  • laugh gas
  • Outcome Measures

    Primary Outcome Measures

    1. Achieving cooperation in Pediatric dentistry numerical scale [less than 60 minutes]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 15 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Children evaluated by a senior pediatric dentist and require a wide treatment of caries, with a high score of anxiety unable to accept dental treatment with nitrous oxide /oxide of 50% in combined with behavioral management in the pediatric dental clinic.
    Exclusion criteria:
    • Children with high potential risk of sedation, snoring, stridor, sleep apnea, maxillofacial malformation, history of airway difficulty, gastro esophageal reflux, reactive airway disease or acute runny nose, cardiac disease, altered mental status, inadequate fasting time.

    • Parental refusal for conscious sedation.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Bnai Zion Medical Center

    Investigators

    • Principal Investigator: Mostafa Somri, M.D., Bnai Zion Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    MOSTAFA.SOMRI, M.D., Bnai Zion Medical Center
    ClinicalTrials.gov Identifier:
    NCT02886351
    Other Study ID Numbers:
    • BnaiZionMC-16-MS-002
    First Posted:
    Sep 1, 2016
    Last Update Posted:
    Sep 1, 2016
    Last Verified:
    Aug 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by MOSTAFA.SOMRI, M.D., Bnai Zion Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 1, 2016